Additionally, in vivo experiments confirm this observation by proving that inhibiting HIF-1α, P4HA1, or P4HA2 in orthotopic tumors, developed via injection of human breast cancer cells into immunodeficient mice, decreases tissue stiffness and fibrosis [99,101]. This evidence concerns the gene HIF1A and breast cancer.